Improving precision in the quantification of cognition using the Montreal Cognitive Assessment and the Mini-Mental State Examination.

Cognitive Impairment in Patients with Coronary Artery Disease; Comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE)

Background & Objective:  Mild cognitive impairment (MCI) is a transient state between normal condition and dementia. Available data indicates that coronary artery diseases (CAD) may increase the risk of MCI. Hence, the early detection of MCI can prevent the progression of cognitive decline. Materials & Methods:  A sample of 65 subjects with degrees of CAD was enrolled to the study. For cogniti...

Evaluating the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Exam (MMSE) for Cognitive Impairment Post Stroke: A Validation Study against the Cognistat

Is the montreal cognitive assessment superior to the mini-mental state examination in detecting subtle cognitive impairment among middle-aged outpatient U.S. Military veterans?

The Montreal Cognitive Assessment (MoCA) is a relatively newly designed test that was developed as a tool to screen patients with mild cognitive problems that are not typically detected by the Mini-Mental State Exam (MMSE). While early research suggests that the MoCA is more sensitive to subtle cognitive impairment than the MMSE, there is concern about potential decreased specificity when using...

Comparison of the Montreal Cognitive Assessment and Mini Mental State Examination Performance in Patients with Parkinson’s Disease with w Low Educational Background

Recognition of early cognitive impairment in Parkinson ́s disease (PD) is important since it represents a risk factor for developing Parkinson’s disease dementia and psychosis. The MiniMental State Examination (MMSE) remains the most commonly used screening instrument for global cognition, even though it has not been specifically validated for use in PD subjects. More recently, the Montreal Cogn...

Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.

Cognitive impairment is one of the earliest, most common, and most disabling non-motor symptoms in Parkinson's disease (PD). Thus, routine screening of global cognitive abilities is important for the optimal management of PD patients. Few global cognitive screening instruments have been developed for or validated in PD patients. The Mini-Mental State Examination (MMSE), Montreal Cognitive Asses...